Cargando…
E7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasion
BACKGROUND: E7080 is an orally active multi-targeted kinase inhibitor whose targets include vascular endothelial growth factor receptors (VEGFR), fibroblast growth factor receptor (FGFR) and platelet derived growth factor receptors (PDGFR). It has been shown to inhibit tumor angiogenesis by targetin...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154179/ https://www.ncbi.nlm.nih.gov/pubmed/21781317 http://dx.doi.org/10.1186/1471-2407-11-309 |